ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,028,000 | +109.7% | 43,774 | +10.4% | 0.01% | +100.0% |
| Q1 2019 | $967,000 | +102.3% | 39,664 | +18.2% | 0.00% | +100.0% |
| Q4 2018 | $478,000 | +24.5% | 33,568 | +32.9% | 0.00% | 0.0% |
| Q3 2018 | $384,000 | -10.3% | 25,267 | -1.0% | 0.00% | 0.0% |
| Q2 2018 | $428,000 | +14.1% | 25,526 | +11.2% | 0.00% | 0.0% |
| Q1 2018 | $375,000 | +31.6% | 22,954 | +3.0% | 0.00% | +100.0% |
| Q4 2017 | $285,000 | +11.3% | 22,293 | +7.2% | 0.00% | 0.0% |
| Q3 2017 | $256,000 | +62.0% | 20,793 | +10.2% | 0.00% | 0.0% |
| Q2 2017 | $158,000 | -12.7% | 18,875 | -6.9% | 0.00% | 0.0% |
| Q1 2017 | $181,000 | +11.0% | 20,272 | +9.6% | 0.00% | 0.0% |
| Q4 2016 | $163,000 | +46.8% | 18,488 | +12.1% | 0.00% | 0.0% |
| Q3 2016 | $111,000 | +113.5% | 16,494 | +13.6% | 0.00% | – |
| Q2 2016 | $52,000 | +44.4% | 14,516 | +18.7% | 0.00% | – |
| Q1 2016 | $36,000 | 0.0% | 12,234 | +21.0% | 0.00% | – |
| Q3 2014 | $36,000 | – | 10,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|